Mohammed Nabil Quraishi

The use of faecal microbiota transplant as treatment for recurrent or refractory<i>Clostridium difficile</i>infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Benjamin H. Mullish, Mohammed Nabil Quraishi, Jonathan Segal et al. · Gut · 2018 · 330 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +11

Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic

Gianluca Ianiro, Benjamin H. Mullish, Colleen Kelly et al. · Gut · 2020 · 150 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways

Mohammed Nabil Quraishi, Animesh Acharjee, Andrew D. Beggs et al. · Journal of Crohn s and Colitis · 2020 · 141 citations · Full text

Life Sciences, Immunology, Microbiology +15

Breastfeeding promotes early neonatal regulatory T‐cell expansion and immune tolerance of non‐inherited maternal antigens

Hannah Wood, Animesh Acharjee, Hayden Pearce et al. · Allergy · 2021 · 83 citations · Full text

Life Sciences, Immunology, Maternal Health +17

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Benjamin H. Mullish, Mohammed Nabil Quraishi, Jonathan Segal et al. · Journal of Hospital Infection · 2018 · 78 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13